Three cases of hypopigmentation in patients of CML (Chronic Myelogenous Leukemia) being treated with Imatinib have been reported in Journal of Association of Physicians of India JAPI.
Source and Detailed Report: JAPI 2007;55:527.
http://www.japi.org/july2007/Corr1.pdf
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment